QbDVision
PrivateLast Round
Series A
Extension
May 1, 2025
Est. Valuation
$53M
Total Funding Raised
$32.41M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
QbDVision is a healthcare technology company that provides a digital Chemistry, Manufacturing, and Controls (CMC) platform for the biopharma industry to accelerate drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Quality Management, Compliance, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QbDVision Comparables
Compare QbDVision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skyland Analytics | 82% | |
| Aizon | 77% | |
| Apprentice | 77% |
QbDVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 1, 2025 | ||||
| Series A | Feb 10, 2022 | ||||
| Seed | Oct 15, 2020 | ||||
| Seed | Jan 30, 2019 |
Key People
Founding team and executive leadership
QbDVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ATX Venture Partners | Seed |
| Cartmell Ventures | Seed |
| Create Health Ventures | Series A Extension |
| Northpond Ventures | Series A Extension, Series A |
| Hudson Park Advisors | Seed, Series A |
| S3 Ventures | Seed, Series A, Series A Extension |
| Wanxiang Healthcare Investments | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 59, 89% of headcount.
- Jul 13, 2026
Open roles increased to 45, representing 68% of headcount.
QbDVision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about QbDVision's valuation, stock price, and market status.
Is QbDVision a public or private company?
QbDVision is a private company.
What is the current stock price of QbDVision?
QbDVision is a private company with no public stock price. No recent secondary market data is available.
How much is QbDVision worth (valuation)?
Valuation information for QbDVision is not publicly available.
Can I buy QbDVision stock?
QbDVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was QbDVision's last funding round?
QbDVision's most recent funding round was Series A Extension on May 1, 2025.
Who are the main investors in QbDVision?
Key investors in QbDVision include Northpond Ventures, S3 Ventures.
Will QbDVision IPO soon?
No public IPO plans have been announced for QbDVision.
How can I track QbDVision secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QbDVision's secondary market activity and sign up for updates.